Who
Madge K. Shafmaster
Director
Company insider
Files Form 4 as: Director, ProMIS Neurosciences.
In numbers
- Trades disclosed
- 9
- Buys
- 3
- Sells
- 0
- Bought
- $256K
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 20 Sep 2024
- Last trade
- 20 May 2026
- Last filed
- 22 May 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 20 May 2026filed 22 May 2026 | PMN ProMIS Neurosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —5,500 at $0.00 | filing |
| 20 May 2026filed 22 May 2026 | PMN ProMIS Neurosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —11,000 at $0.00 | filing |
| 20 May 2026filed 22 May 2026 | PMN ProMIS Neurosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —5,500 at $0.00 | filing |
| 20 May 2026filed 22 May 2026 | PMN ProMIS Neurosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —11,000 at $0.00 | filing |
| 12 Jun 2025filed 16 Jun 2025 | PMN ProMIS Neurosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
| 3 Oct 2024filed 7 Oct 2024 | PMN ProMIS Neurosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —40,000 at $0.00 | filing |
| 24 Sep 2024filed 24 Sep 2024 | PMN ProMIS NeurosciencesBiotechnology | SEC FORM 4 Bought | $91K70,000 at $1.30 | filing |
| 23 Sep 2024filed 24 Sep 2024 | PMN ProMIS NeurosciencesBiotechnology | SEC FORM 4 Bought | $90K70,000 at $1.28 | filing |
| 20 Sep 2024filed 24 Sep 2024 | PMN ProMIS NeurosciencesBiotechnology | SEC FORM 4 Bought | $75K60,000 at $1.25 | filing |
News
No headline names them, or the companies they trade most, lately.